Int J Stomatol

Int J Stomatol ›› 2021, Vol. 48 ›› Issue (2): 213-217.doi: 10.7518/gjkq.2021027

• Reviews • Previous Articles     Next Articles

Oral and maxillofacial manifestations of Ehlers-Danlos syndrome

Liu Shuai1,2(),Wang Ningxiang1,3,Lin Liangyuan4,Wu Juan1()   

  1. 1. Dept. of Periodontology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China
    2. Dept. of Stomatology, Nanjing Lishui District Hospital of Traditional Chinese Medicine, Nanjing 211200, China
    3. Dept. of Stomatology, Nanjing Hospital of Chinese Medicine, Nanjing University of Traditional Chinese Medicine, Nanjing 210001, China
    4. Dept. of Stomatology, Children,s Hospital of Nanjing Medical University, Nanjing 210029, China
  • Received:2020-06-21 Revised:2020-10-31 Online:2021-03-01 Published:2021-03-17
  • Contact: Juan Wu E-mail:1729624217@qq.com;56868794@qq.com
  • Supported by:
    Medical Science and Technology Development Foundation, Nanjing Department of Health(YKK18121);Natural Science Foundation of Jiangsu Province(BK20200149)

RichHTML

34

PDF (PC)

135

Abstract:

Ehlers-Danlos syndromes (EDS) belong to a clinically and genetically heterogeneous group of rare hereditary disorders characterised by varying degrees of connective tissue fragility, which affects the skin, ligaments, blood vessels and internal organs. Principal clinical features include tissue fragility, skin extensibility and joint hypermobility. Published data on the oral and maxillofacial manifestations of EDS are limited, but literature search found that almost all types of EDS have oral and maxillofacial changes, and these changes are often not correctly recognised by clinicians. This article reviews the oral and maxillofacial manifestations of EDS to provide reference for clinicians.

Key words: Ehlers-Danlos syndrome, oral, maxillofacial

CLC Number: 

  • R782.2

TrendMD: 
[1] Malfait F, Castori M, Francomano CA, et al. The ehlers-danlos syndromes[J]. Nat Rev Dis Primers, 2020,6:64.
[2] Malfait F, Francomano C, Byers P, et al. The 2017 international classification of the Ehlers-Danlos syndromes[J]. Am J Med Genet C Semin Med Genet, 2017,175(1):8-26.
[3] Mitakides JE. The effect of Ehlers-Danlos syndromes on TMJ function and craniofacial pain[J]. Cranio, 2018,36(2):71-72.
[4] Abel MD, Carrasco LR. Ehlers-Danlos syndrome: classifications, oral manifestations, and dental considerations[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006,102(5):582-590.
[5] Mitakides J, Tinkle BT. Oral and mandibular manifestations in the Ehlers-Danlos syndromes[J]. Am J Med Genet C Semin Med Genet, 2017,175(1):220-225.
doi: 10.1002/ajmg.c.31541 pmid: 28192626
[6] Bowen JM, Sobey GJ, Burrows NP, et al. Ehlers-Danlos syndrome, classical type[J]. Am J Med Ge-net C Semin Med Genet, 2017,175(1):27-39.
[7] De Felice C, Bianciardi G, Dileo L, et al. Abnormal oral vascular network geometric complexity in Ehlers-Danlos syndrome[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2004,98(4):429-434.
pmid: 15472658
[8] De Coster PJ, Martens LC, De Paepe A. Oral health in prevalent types of Ehlers-Danlos syndromes[J]. J Oral Pathol Med, 2005,34(5):298-307.
pmid: 15817074
[9] Perrinaud A, Matos M, Maruani A, et al. Absence of inferior labial or lingual frenula in Ehlers-Danlos syndrome: a new diagnostic criterion[J]. Ann Dermatol Venereol, 2007,134(11):859-862.
pmid: 18033068
[10] Byers PH, Belmont J, Black J, et al. Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome[J]. Am J Med Genet C Semin Med Genet, 2017,175(1):40-47.
doi: 10.1002/ajmg.c.31553 pmid: 28306228
[11] Machet L, Hüttenberger B, Georgesco G, et al. Absence of inferior labial and lingual frenula in Ehlers-Danlos syndrome: a minor diagnostic criterion in French patients[J]. Am J Clin Dermatol, 2010,11(4):269-273.
pmid: 20143893
[12] Ferré FC, Frank M, Gogly B, et al. Oral phenotype and scoring of vascular Ehlers-Danlos syndrome: a case-control study[J]. BMJ Open, 2012,2(2):e000705.
[13] Colebatch AN, Shaw EC, Foulds NC, et al. Hemorrhagic bullae of the oral mucosa as an early manifestation of vascular-type ehlers-danlos syndrome[J]. J Clin Rheumatol, 2011,17(7):383-384.
[14] Tinkle B, Castori M, Berglund B, et al. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome type Ⅲ and Ehlers-Danlos syndrome hypermobility type): clinical description and natural history[J]. Am J Med Genet C Semin Med Genet, 2017,175(1):48-69.
pmid: 28145611
[15] Jerjes W, Upile T, Shah P, et al. TMJ arthroscopy in patients with Ehlers Danlos syndrome: case series[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2010,110(2):e12-e20.
pmid: 20659691
[16] Diep D, Fau V, Wdowik S, et al. Temporomandibular disorders and Ehlers-Danlos syndrome, hypermobility type: a case-control study[J]. Rev Stomatol Chir Maxillofac Chir Orale, 2016,117(4):228-233.
pmid: 27522240
[17] Castori M, Dordoni C, Morlino S, et al. Spectrum of mucocutaneous manifestations in 277 patients with joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type[J]. Am J Med Genet C Semin Med Genet, 2015,169C(1):43-53.
pmid: 25655071
[18] Kapferer-Seebacher I, Pepin M, Werner R, et al. Periodontal ehlers-danlos syndrome is caused by mutations in C1R and C1S, which encode subcomponents C1r and C1s of complement[J]. Am J Hum Genet, 2016,99(5):1005-1014.
[19] Cunniff C, Williamson-Kruse L. Ehlers-Danlos syndrome, type Ⅷ presenting with periodontitis and prolonged bleeding time[J]. Clin Dysmorphol, 1995,4(2):145-149.
[20] Biesecker LG, Erickson RP, Glover TW, et al. Molecular and cytologic studies of Ehlers-Danlos syndrome type Ⅷ[J]. Am J Med Genet, 1991,41(3):284-288.
[21] Kapferer-Seebacher I, Lundberg P, Malfait F, et al. Periodontal manifestations of Ehlers-Danlos syndromes: a systematic review[J]. J Clin Periodontol, 2017,44(11):1088-1100.
pmid: 28836281
[22] Cartault F, Munier P, Jacquemont ML, et al. Expan-ding the clinical spectrum of B4GALT7 deficiency: homozygous p.R270C mutation with founder effect causes Larsen of Reunion Island syndrome[J]. Eur J Hum Genet, 2015,23(1):49-53.
pmid: 24755949
[23] Nakajima M, Mizumoto S, Miyake N, et al. Mutations in B3GALT6, which encodes a glycosaminoglycan linker region enzyme, cause a spectrum of skeletal and connective tissue disorders[J]. Am J Hum Genet, 2013,92(6):927-934.
doi: 10.1016/j.ajhg.2013.04.003 pmid: 23664117
[24] Caraffi SG, Maini Ⅰ, Ivanovski Ⅰ, et al. Severe peripheral joint laxity is a distinctive clinical feature of spondylodysplastic-ehlers-danlos syndrome (EDS)-B4GALT7 and spondylodysplastic-EDS-B3GALT6[J]. Genes (Basel), 2019,10(10):E799.
[25] Brady AF, Demirdas S, Fournel-Gigleux S, et al. The Ehlers-Danlos syndromes, rare types[J]. Am J Med Genet C Semin Med Genet, 2017,175(1):70-115.
doi: 10.1002/ajmg.c.31550 pmid: 28306225
[26] Ayoub S, Ghali N, Angwin C, et al. Clinical features, molecular results, and management of 12 individuals with the rare arthrochalasia Ehlers-Danlos syndrome[J]. Am J Med Genet A, 2020,182(5):994-1007.
[27] van Damme T, Colige A, Syx D, et al. Expanding the clinical and mutational spectrum of the Ehlers-Danlos syndrome, dermatosparaxis type[J]. Genet Med, 2016,18(9):882-891.
pmid: 26765342
[28] Lautrup CK, Teik KW, Unzaki A, et al. Delineation of musculocontractural Ehlers-Danlos syndrome cau-sed by dermatan sulfate epimerase deficiency[J]. Mol Genet Genomic Med, 2020,8(5):e1197.
pmid: 32130795
[29] Evers MR, Xia GQ, Kang HG, et al. Molecular clo-ning and characterization of a dermatan-specificN-acetylgalactosamine 4-O-sulfotransferase[J]. J Biol Chem, 2001,276(39):36344-36353.
doi: 10.1074/jbc.M105848200 pmid: 11470797
[30] Kosho T. CHST14/D4ST1 deficiency: new form of Ehlers-Danlos syndrome[J]. Pediatr Int, 2016,58(2):88-99.
pmid: 26646600
[1] He Zimu, Li Fenglan. Present application of digital oral positioning stents in radiotherapy of head and neck tumor [J]. Int J Stomatol, 2024, 51(1): 28-35.
[2] Fu Yu, He Wei, Huang Lan. Ferroptosis and its implication in oral diseases [J]. Int J Stomatol, 2024, 51(1): 36-44.
[3] Li Ran,Hu Yue,Zhang Ning,Gao Ruifang,Wang Xiangyu,Ge Xuejun. The correlation study between single nucleotide polymorphisms of Toll-like receptor and interleukin-17 and oral lichen planus [J]. Int J Stomatol, 2024, 51(1): 45-51.
[4] Zhou Jinkuo,Zhang Jinhong,Shi Xiaojing,Liu Guangshun,Jiang Lei,Liu Qianfeng. Influences of long noncoding RNA small nucleolar RNA host gene 22 on the cell proliferation, invasion and migration of oral squamous carcinoma cells by regulating microRNA-27b-3p [J]. Int J Stomatol, 2024, 51(1): 52-59.
[5] Li Liheng,Wang Rui,Wang Xiaoming,Zhang Zhiyi,Zhang Xuan,An Feng,Wang Qin,Zhang Fan. Effects of circular RNA hsa_circ_0085576 on cell migration and invasion of oral squamous cell carcinoma by regulating the microRNA-498/B-cell-specific Moloney murine leukemia virus integration site 1 axis [J]. Int J Stomatol, 2024, 51(1): 60-67.
[6] Xia Weiyao,Jia Zhonglin. Research progress on the relationship between vitamin and oral clefts [J]. Int J Stomatol, 2023, 50(6): 632-638.
[7] Wang Sujie,Tan Qin,Wei Yuan,Wang Jie,Fan Jie,Yue Erli.. Correlation analysis of serum angiopoietin-2 level with forkhead/winged helix transcription factor p3 regulatory T cells and disease activity in patients with oral lichen planus [J]. Int J Stomatol, 2023, 50(6): 674-678.
[8] Lu Lei,Wang Xin,Kang Zebiao,Xie Fuqiang. Research progress on the application of computer-assisted navigation surgery in complex maxillofacial fractures [J]. Int J Stomatol, 2023, 50(6): 696-703.
[9] Wu Jiamin,Xia Bin,Yang Hefeng,Xu Biao.. Research progress on cancer-associated fibroblasts in the tumor microenvironment of oral squamous cell carcinoma [J]. Int J Stomatol, 2023, 50(6): 711-717.
[10] Liu Jianglong, Tuerdi Maimaitituxun. Progress of contrast-enhanced ultrasound in the diagnosis of cervical lymph node metastasis from oral squamous cell carcinoma [J]. Int J Stomatol, 2023, 50(5): 514-520.
[11] Liu Ting,Wu Xiuping.. Research progress on oral-craniomaxillofacial features and treatment of Down syndrome [J]. Int J Stomatol, 2023, 50(5): 618-622.
[12] Jiang Yueying,He Yutian,Li Ting,Zhou Ronghui.. Research progress on the application of near infrared fluorescence probe in the diagnosis of oral cancer [J]. Int J Stomatol, 2023, 50(4): 407-413.
[13] Wang Lüya,Zhang Jingxin,Lin Jie.. Postoperative infection control effect of povidone iodine and chlorhexidine: a systematic review and analysis [J]. Int J Stomatol, 2023, 50(4): 438-444.
[14] Wu Yifan,Lu Hao,Liu Shengwen,Xu Wanlin,Yang Wenjun.. Gorham-Stout disease in maxillofacial bone: a case report and literature review [J]. Int J Stomatol, 2023, 50(4): 445-451.
[15] Fan Lin,Sun Jiang.. Application of microneedles in stomatology [J]. Int J Stomatol, 2023, 50(4): 472-478.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[7] . [J]. Foreign Med Sci: Stomatol, 2005, 32(06): 458 -460 .
[8] . [J]. Foreign Med Sci: Stomatol, 2005, 32(06): 452 -454 .
[9] . [J]. Inter J Stomatol, 2008, 35(S1): .
[10] . [J]. Inter J Stomatol, 2008, 35(S1): .